NeurAxis (NASDAQ:NRXS) Stock Price Down 3.3%

NeurAxis, Inc. (NASDAQ:NRXS) was down 3.3% on Friday . The stock traded as low as $2.53 and last traded at $2.61. Approximately 23,584 shares traded hands during trading, an increase of 112% from the average daily volume of 11,130 shares. The stock had previously closed at $2.70.

NeurAxis Stock Performance

The business has a 50-day simple moving average of $3.07 and a 200-day simple moving average of $2.95. The company has a market cap of $17.36 million and a price-to-earnings ratio of -0.70.

NeurAxis (NASDAQ:NRXS) last released its earnings results on Monday, May 20th. The company reported ($0.32) earnings per share for the quarter. The company had revenue of $0.65 million for the quarter.

Hedge Funds Weigh In On NeurAxis

A hedge fund recently bought a new stake in NeurAxis stock. Parsons Capital Management Inc. RI acquired a new position in shares of NeurAxis, Inc. (NASDAQ:NRXS) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 13,000 shares of the company’s stock, valued at approximately $35,000. Parsons Capital Management Inc. RI owned approximately 0.25% of NeurAxis as of its most recent filing with the SEC. 11.77% of the stock is currently owned by institutional investors.

About NeurAxis

NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.